Effect of parental autoimmune diseases on type 1 diabetes in offspring can be partially explained by HLA and non-HLA polymorphisms: a nationwide registry and biobank-based study in 7.2M Finns

Data Availability

Data description for FinRegistry is publicly available on its website (www.finregistry.fi/finnish-registry -data). Access to FinRegistry data at an individual level is possible by submitting a data permit application (https://asiointi.findata.fi). The application includes information on the purpose of data use; the requested data, including the variables, definitions for the target and control groups, and external datasets to be combined with FinRegistry data; the dates of the data needed; and a data utilization plan. The requests will be evaluated on a case-by-case basis. Once approved, the data will be sent to a secure environment Kapseli and can be accessed within the European Economic Area (EEA) and within countries with an adequacy decision from the European Commission. The Finnish biobank data can be accessed through the Fingenious services (https://site.fingenious.fi/en/) managed by FINBB.